Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
Shopping Cart: ( empty )
You are here: Home > Journals > SH > SH08033
EDITORIAL
Contents Vol 5(3)

Making the most of episodic antiviral therapy for genital herpes

Raj Patel
+ Author Affiliations
- Author Affiliations

University of Southampton, Royal South Hants Hospital, St Marys Road, Southampton SO14 OYG, UK. Email: prj466@aol.com

Sexual Health 5(3) 213-214 https://doi.org/10.1071/SH08033
Submitted: 8 May 2008  Accepted: 12 May 2008   Published: 6 August 2008


References


[1] Spruance SL,  Overall JC,  Kern ER,  Krueger GG,  Pliam V,  Miller W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 1977; 297 69–75.
|  CAS | PubMed |

[2] Spruance SL,  Bodsworth N,  Resnick H,  Conant M,  Oeuvray C,  Gao J, et al. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol 2006; 55 47–53.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[3] Corey L. Genital herpes. In: Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ (eds). Sexually transmitted diseases, 2nd edn. New York: McGraw-Hill; 1990. pp. 397–8.

[4] Wald A,  Carrell D,  Remington M,  Kexel E,  Zeh J,  Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002; 34 944–8.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[5] Leone PA,  Trottier S,  Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002; 34 958–62.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[6] Strand A,  Patel R,  Wulf HC,  Coates KM,  International Valaciclovir HSV Study Group . Aborted genital herpes simplex virus lesions: findings from a randomized controlled trial with Valaciclovir. Sex Transm Infect 2002; 78 435–9.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[7] Aoki FY,  Tyring S,  Diaz-Mitoma F,  Gross G,  Gao J,  Hamed K. Single-day patient initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2006; 42 8–13.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[8] Bodsworth N,  Bloch M,  McNulty A,  Denham I,  Doong N,  Trottier S, et al. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study. Sex Health 2008; 5 219–225.
| Crossref | GoogleScholarGoogle Scholar |